Patents by Inventor Nobuyuki Udagawa

Nobuyuki Udagawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic Agent for Osteoporosis Using a Retinoid X Receptor-Related Compound
    Publication number: 20090270612
    Abstract: It is an object of the present invention to provide a novel therapeutic agent for osteoporosis. HX531 is utilized, which is synthesized as a retinoid X receptor antagonist and has an activity in inhibiting a differentiation into adipocytes. Furthermore, any dosage form containing HX531 as an effective component can be used.
    Type: Application
    Filed: September 4, 2006
    Publication date: October 29, 2009
    Inventors: Nobuyuki Udagawa, Midori Nakamura, Hiroyuki Kagechika
  • Method for treating a disease associated with excessive osteoclast formation
    Patent number: 6896880
    Abstract: An osteoclastgenic inhibitory agent which comprises an interleukin-18 and/or its functional equivalent. The agent can be arbitrarily used as an ingredient for cell culture and agents for regulating bone resorption and for osteoclast-related diseases, directed to treat and/or prevent hypercalcemia, osteoclastoma, osteoporosis, etc.
    Type: Grant
    Filed: March 19, 2002
    Date of Patent: May 24, 2005
    Assignee: Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo
    Inventors: Matthew Todd Gillispie, Nicole Joy Horwood, Nobuyuki Udagawa, Masashi Kurimoto
  • IL-18 AS AN OSTEOCLASTGENIC INHIBITOR
    Publication number: 20030095946
    Abstract: An osteoclastgenic inhibitory agent which comprises an interleukin-18 and/or its functional equivalent. The agent can be arbitrarily used as an ingredient for cell culture and agents for regulating bone resorption and for osteoclast-related diseases, directed to treat and/or prevent hypercalcemia, osteoclastoma, osteoporosis, etc.
    Type: Application
    Filed: February 25, 1998
    Publication date: May 22, 2003
    Inventors: MATTHEW TODD GILLSPIE, NICOLE JOY HORWOOD, NOBUYUKI UDAGAWA, MASASHI KURIMOTO
  • Osteoclastgenic inhibitory agent
    Publication number: 20020150555
    Abstract: An osteoclastgenic inhibitory agent which comprises an interleukin-18 and/or its functional equivalent. The agent can be arbitrarily used as an ingredient for cell culture and agents for regulating bone resorption and for osteoclast-related diseases, directed to treat and/or prevent hypercalcemia, osteoclastoma, osteoporosis, etc.
    Type: Application
    Filed: March 19, 2002
    Publication date: October 17, 2002
    Applicant: KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO
    Inventors: Matthew Todd Gillispie, Nicole Joy Horwood, Nobuyuki Udagawa, Masashi Kurimoto